These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 24102745)

  • 1. PD First: peritoneal dialysis as the default transition to dialysis therapy.
    Ghaffari A; Kalantar-Zadeh K; Lee J; Maddux F; Moran J; Nissenson A
    Semin Dial; 2013; 26(6):706-13. PubMed ID: 24102745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal dialysis: misperceptions and reality.
    Saxena R
    Am J Med Sci; 2014 Sep; 348(3):250-61. PubMed ID: 24875660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What influences patient choice of treatment modality at the pre-dialysis stage?
    Chanouzas D; Ng KP; Fallouh B; Baharani J
    Nephrol Dial Transplant; 2012 Apr; 27(4):1542-7. PubMed ID: 21865216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined peritoneal dialysis and hemodialysis therapy improves quality of life in end-stage renal disease patients.
    Hashimoto Y; Matsubara T
    Adv Perit Dial; 2000; 16():108-12. PubMed ID: 11045273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding criteria for peritoneal dialysis use.
    Palomar R; Arias M
    Panminerva Med; 2009 Sep; 51(3):139-50. PubMed ID: 19859049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal dialysis or hemodialysis? A dilemma for the nephrologist.
    Shahab I; Khanna R; Nolph KD
    Adv Perit Dial; 2006; 22():180-5. PubMed ID: 16983966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal Dialysis Use and Practice Patterns: An International Survey Study.
    Cho Y; Bello AK; Levin A; Lunney M; Osman MA; Ye F; Ashuntantang GE; Bellorin-Font E; Gharbi MB; Davison SN; Ghnaimat M; Harden P; Htay H; Jha V; Kalantar-Zadeh K; Kerr PG; Klarenbach S; Kovesdy CP; Luyckx V; Neuen B; O'Donoghue D; Ossareh S; Perl J; Rashid HU; Rondeau E; See EJ; Saad S; Sola L; Tchokhonelidze I; Tesar V; Tungsanga K; Kazancioglu RT; Yee-Moon Wang A; Yang CW; Zemchenkov A; Zhao MH; Jager KJ; Caskey FJ; Jindal KK; Okpechi IG; Tonelli M; Harris DC; Johnson DW
    Am J Kidney Dis; 2021 Mar; 77(3):315-325. PubMed ID: 32800844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing Landscape for Peritoneal Dialysis: Optimizing Utilization.
    Schreiber MJ
    Semin Dial; 2017 Mar; 30(2):149-157. PubMed ID: 28144977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
    Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
    Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting the use of peritoneal dialysis among the ESRD population in India: a single-center study.
    Mahajan S; Tiwari SC; Kalra V; Bhowmik DM; Agarwal SK
    Perit Dial Int; 2004; 24(6):538-41. PubMed ID: 15559482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal Dialysis or Hemodialysis: Present and Future Trends in the United States.
    Kaplan AA
    Contrib Nephrol; 2017; 189():61-64. PubMed ID: 27951550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing dialysis modality for end-stage renal disease in developing countries: a survey of Filipino nephrologists.
    Cruz DN; Troidle L; Danguilan R; Padilla B; Frando L; Sebastian E; Sy-Lim A; Luz V; Finkelstein F
    Blood Purif; 2011; 32(2):117-23. PubMed ID: 21540587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.
    Wong CKH; Chen J; Fung SKS; Mok M; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
    BMC Nephrol; 2020 Feb; 21(1):42. PubMed ID: 32019528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodialysis versus peritoneal dialysis, which is cost-effective?
    Atapour A; Eshaghian A; Taheri D; Dolatkhah S
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):962-5. PubMed ID: 26354569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis.
    Mehrotra R; Marsh D; Vonesh E; Peters V; Nissenson A
    Kidney Int; 2005 Jul; 68(1):378-90. PubMed ID: 15954930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The United States' perspectives on home dialysis.
    Qamar M; Bender F; Rault R; Piraino B
    Adv Chronic Kidney Dis; 2009 May; 16(3):189-97. PubMed ID: 19393969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of peritoneal dialysis at Rijeka Clinical Hospital Center].
    Zivcić-Cosić S; Vlahović A; Grzetić M; Matić-Glazar D
    Acta Med Croatica; 2004; 58(3):215-20. PubMed ID: 15503685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy.
    Goovaerts T; Jadoul M; Goffin E
    Nephrol Dial Transplant; 2005 Sep; 20(9):1842-7. PubMed ID: 15919693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.